| Literature DB >> 3612975 |
Abstract
Entities:
Mesh:
Substances:
Year: 1987 PMID: 3612975 PMCID: PMC9536525
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 157.335
Figure 1Flowchart of the protocol.
Study phases.
| Phases and activities | 2021 | 2022 | ||||
|
| October | November | December | January | February | |
|
| ||||||
|
| Contact the authors of the instrument | ✓ |
|
|
|
|
|
| Review the theoretical framework and search for bibliographical references | ✓ | ✓ |
|
|
|
|
| Analysis of the validation process developed in other countries |
| ✓ |
|
|
|
|
| Preparation of an informed consent document for patients | ✓ |
|
|
|
|
|
| Drafting of a document for the research ethics committee | ✓ |
|
|
|
|
|
| Elaboration of research protocol and acceptance by the authors | ✓ | ✓ |
|
|
|
|
| Research ethics committee authorization |
| ✓ |
|
|
|
|
| ||||||
|
| Briefing of experts on the translation process of the tool | ✓ |
|
|
|
|
|
| Comparison of the versions translated by both groups of experts and consensus |
| ✓ |
|
|
|
|
| Back-translation of the final version by a certified body |
| ✓ |
|
|
|
|
| Contact the authors to show them the translated version |
| ✓ |
|
|
|
|
| Briefing meeting with the nursing professionals who will evaluate the first translated version in practice |
| ✓ |
|
|
|
|
| Compilation of the study sample |
| ✓ | ✓ | ✓ |
|
|
| Statistical analysis |
|
|
| ✓ |
|
|
| Interpretation of the results obtained |
|
|
| ✓ | ✓ |
|
| Organization of the data obtained |
|
|
| ✓ | ✓ |
|
| Elaboration of the discussion and conclusion |
|
|
| ✓ | ✓ |
|
| Presentation to the authors of the draft and review of contributions |
|
|
|
| ✓ |
|
| Selection of the most appropriate journal for dissemination |
|
|
|
| ✓ |
|
| ||||||
|
| Submission of the work to a journal of scientific interest |
|
|
|
| ✓ |
|
| Organization of a conference to present the results to the health network |
|
|
|
| ✓ |
|
| Presentation of the validation process at a national or international congress of scientific interest |
|
|
|
| ✓ |
|
| Working meeting on the process: aspects for improvement, strengths, weaknesses, and opportunities |
|
|
|
| ✓ |